Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia

Autor: Serena Xodo, Sabina Cauci, Giuseppe Toffoli, Erika Cecchin, Giovanni Chiriaco, Carlo Trombetta, Giuseppe Stinco
Přispěvatelé: Cauci, Sabina, Chiriacò, Giovanni, Cecchin, Erika, Toffoli, Giuseppe, Xodo, Serena, Stinco, Giuseppe, Trombetta, Carlo
Rok vydání: 2016
Předmět:
Endocrinology
Diabetes and Metabolism

Loss of Libido
lcsh:Medicine
Gastroenterology
CAG polymorphism
PFS
Post-Finasteride Syndrome
chemistry.chemical_compound
Behavioral Neuroscience
0302 clinical medicine
Endocrinology
Basic Science
loss of libido
Erectile Dysfunction
androgen receptor
finasteride safety
Medicine
Finasteride Side Effect
Young male
Original Research
030219 obstetrics & reproductive medicine
5alpha-reductase inhibitor
post-finasteride syndrome
male pattern hair loss
AGA
GGN polymorphism
erectile dysfunction
sexual dysfunction
finasteride side effects
lcsh:Other systems of medicine
Pathophysiology
Psychiatry and Mental health
Androgen Receptor
Finasteride
Androgenic Alopecia
medicine.symptom
Psychology
Finasteride Safety
Long lasting
medicine.medical_specialty
Sexual Dysfunction
Urology
030209 endocrinology & metabolism
Dermatology
GGN Polymorphism
03 medical and health sciences
Internal medicine
Adverse effect
Gene
business.industry
lcsh:R
5α-Reductase Inhibitor
medicine.disease
CAG Polymorphism
Finasteride Side Effects
Male Pattern Hair Loss
Reproductive Medicine
2708
lcsh:RZ201-999
Discontinuation
Androgen receptor
Erectile dysfunction
Sexual dysfunction
chemistry
business
Male Pattern Hair Lo
Zdroj: Sexual Medicine, Vol 5, Iss 1, Pp e61-e71 (2017)
Sexual Medicine
ISSN: 2050-1161
DOI: 10.1016/j.esxm.2016.11.001
Popis: Introduction Long-term adverse symptoms of men who used oral finasteride against androgenic alopecia have been recently described as post-finasteride syndrome (PFS). Aim To determine whether (CAG)n-rs4045402 and (GGN)n-rs3138869 polymorphisms in the androgen receptor (AR) gene are implicated in PFS. Methods AR polymorphisms were studied according to PFS symptoms in 66 white participants (31.8% Italian, 28.8% American, and 39.4% other). Main Outcome Measures Symptoms were investigated by an ad hoc 100-item questionnaire and the Arizona Sexual Experience Scale and Aging Male Symptom Scale (AMS). (CAG)n and (GGN)n repeats were categorized as short ([CAG]9–19, [GGN]23). Results Median age was 32 years, duration of finasteride use was 360 days, and time from finasteride discontinuation was 1,053 days. We observed several frequency differences in symptoms according to (CAG)n and (GGN)n repeat numbers. Three AMS items were worse for medium (GGN)23 than for long (GGN)>23 carriers and one item was worse for short (GGN)2 kg), increased skin dryness, and onset of symptoms after finasteride use. Conclusion This study showed that short and/or long (CAG)n and (GGN)n repeats had different frequencies according to symptoms reported by patients with PFS, likely reflecting the vast array of genes modulated by the AR. This study showed a U-curvilinear profile of (CAG)n repeats for skin dryness symptoms, where the two extremes exhibited a worse condition than medium repeats. Further studies are necessary to investigate the PFS pathophysiology using a precision medicine approach.
Databáze: OpenAIRE